Beranda › Pneumonia
Uji klinis Pneumonia yang merekrut di AS
31 studi untuk Pneumonia merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX8 studi
- Chicago, IL6 studi
- Salt Lake City, UT6 studi
- Washington, DC5 studi
- Durham, NC5 studi
- Boston, MA5 studi
- Hialeah, FL4 studi
- Dallas, TX4 studi
- Cincinnati, OH4 studi
- Philadelphia, PA4 studi
- St. Louis, MO4 studi
- Atlanta, GA4 studi
- Los Angeles, CA4 studi
- San Francisco, CA3 studi
- Baltimore, MD3 studi
- Miami, FL3 studi
- Charleston, SC3 studi
- San Diego, CA3 studi
- Worcester, MA3 studi
- Ann Arbor, MI3 studi
- Mountain View, CA3 studi
- New Orleans, LA3 studi
- Cleveland, OH3 studi
- New York City, NY3 studi
- Columbus, OH3 studi
Berdasarkan negara bagian
- California12 studi
- Colorado3 studi
- Distrik Columbia3 studi
- Florida7 studi
- Georgia6 studi
- Illinois7 studi
- Kentucky3 studi
- Louisiana4 studi
- Maryland6 studi
- Massachusetts6 studi
- Michigan4 studi
- Missouri6 studi
- New Jersey4 studi
- New York6 studi
- North Carolina6 studi
- Ohio10 studi
- Pennsylvania9 studi
- South Carolina4 studi
- Tennessee4 studi
- Texas9 studi
- Utah7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05848713Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Month – 120 Years · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00006150A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Study of Lung Proteins in Patients With Pneumonia
Menerima pesertaStudi observasional
Usia 3 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00077909Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05041140Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Menerima peserta
Usia 65 hingga 100 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06495021A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT07730450The Effects of Endotracheal Suctioning on Pain and Serum Markers
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06692400A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT07615010iNO300 Therapy in Critically Ill Patients With Pneumonia
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06950294A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Menerima pesertaStudi observasional
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT05452941PET Imaging CCR2 in Lung Inflammation
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT03492762Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06688422Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
Menerima peserta
Usia 3 hingga 10 · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT06921993Immune Defense Protein Impact On Respiratory Immune Outcomes
Menerima pesertaSukarelawan sehat diterima
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07431840The APS Phenotyping Study
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT06521502The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Feb 2026 · NCT03482245Performance of New Diagnostic Methods in Older Adults With Pneumonia
Menerima pesertaStudi observasional
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT06092008Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
Menerima peserta
12 Months – 71 Months · Semua jenis kelamin · Diperbarui 27 Jan 2026 · NCT06986148Reducing Overuse of Antibiotics With Decision Support
Menerima peserta
6 Months – 17 Years · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT06788093Cough Capture as a Portal Into the Lung
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 13 Jan 2026 · NCT05854563Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Menerima peserta
Hingga usia 18 · Semua jenis kelamin · Diperbarui 10 Des 2025 · NCT05471908Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.